论文部分内容阅读
目的对反复自然流产免疫治疗的临床效果进行评价分析,为今后的临床治疗工作提供可靠的参考依据。方法抽取在2011年7月~2013年12月间本院收治的临床确诊反复自然流产患者68例,对其采取主动免疫疗法进行治疗,并对治疗前后患者抗丈夫淋巴细胞毒抗体(APLA)阳性率进行对比分析。结果本组68例患者经主动免疫治疗后再次妊娠成功者52例,成功率为76.47%,治疗后APLA阳性率较治疗前发生显著升高(P<0.05)。结论主动免疫疗法在反复自然流产中疗效显著,值得关注。
Objective To evaluate the clinical effects of repeated abortion immunotherapy and provide a reliable reference for future clinical treatment. Methods Seventy-eight patients with clinically confirmed recurrent spontaneous abortion admitted in our hospital from July 2011 to December 2013 were enrolled in this study. They were treated with active immunotherapy and positive for anti-Hab Lymphocyte Antibody (APLA) before and after treatment Rate of comparative analysis. Results In the 68 cases of active pregnancy, 52 cases of successful pregnancy were successful, the success rate was 76.47%. The positive rate of APLA after treatment was significantly higher than that before treatment (P <0.05). Conclusion Active immunotherapy has significant curative effect in recurrent spontaneous abortion, which deserves attention.